Geneos Wealth Management Inc. Inovio Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$4.99 - $7.46 $3,742 - $5,595	-750 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$7.16 - $9.69 $3,580 - $4,845	-500 Reduced 40.0%	750 $5,000
Q2 2021 Jul 08, 2021	SELL	$6.23 - $10.03 $8,099 - $13,039	-1,300 Reduced 50.98%	1,250 $11,000
Q4 2020 May 19, 2021	BUY	$8.5 - $12.85 $15,300 - $23,130	1,800 Added 240.0%	2,550 $11,000
Q3 2020 Sep 07, 2021	SELL	$9.57 - $27.05 $1,914 - $5,410	-200 Reduced 21.05%	750 $12,000
Q2 2020 Sep 07, 2021	BUY	$7.14 - $31.69 $5,355 - $23,767	750 Added 375.0%	950 $28,000
Q1 2020 Sep 07, 2021	SELL	$2.98 - $14.09 $298 - $1,409	-100 Reduced 33.33%	200 $1,000
Q4 2019 Sep 07, 2021	BUY	$1.97 - $3.72 $591 - $1,116	300 New	300 $1,000
Q2 2019 Sep 07, 2021	SELL	$2.29 - $4.1 $687 - $1,230	-300 Closed	0 $0
Q4 2016 Sep 07, 2021	SELL	N/A	-25 Reduced 7.69%	300 $2,000
Q2 2016 Sep 07, 2021	SELL	N/A	-500 Reduced 60.61%	325 $3,000
Q1 2016 Sep 07, 2021	BUY	N/A	825	825 $7,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $990M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.